ADURO BIOTECH
Develop early stage cancer therapies
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination 4th Quarter 2020
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
3rd Quarter - Report 3rd Quarter 2020
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
2nd Quarter - Report 2nd Quarter 2020
|
INNOVATIVE FEDERAL STRATEGIES, LLC | $10,000 reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2020
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2019
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2019
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2019
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2019
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
|
4th Quarter - Termination 4th Quarter 2018
|
U.S. GOVERNMENT RELATIONS INTL. | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2018
|
INNOVATIVE FEDERAL STRATEGIES, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| INNOVATIVE FEDERAL STRATEGIES, LLC | 47 | $480,000 |
| U.S. GOVERNMENT RELATIONS INTL. | 9 | $60,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Budget/Appropriations | BUD | 32 |
| Defense | DEF | 16 |
| Government Issues | GOV | 16 |
| Pharmacy | PHA | 10 |
| Medical/Disease Research/Clinical Labs | MED | 3 |
| Health Issues | HCR | 1 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| H.R. 2397 | 113th | 4 |
| H.R. 2685 | 114th | 3 |
| S. 3000 | 114th | 3 |
| S. 1558 | 114th | 3 |
| H.R. 5293 | 114th | 3 |
| S. 1429 | 113th | 3 |
| H.R. 5856 | 112th | 3 |
| H.R. 1540 | 112th | 3 |
| H.R. 4310 | 112th | 3 |
| H.R. 5136 | 111th | 3 |
| H.R. 2647 | 111th | 3 |
| H.R. 4870 | 113th | 2 |
| S. 1253 | 112th | 2 |
| H.R. 2219 | 112th | 2 |
| H.R. 3326 | 111th | 2 |
| H.R. 933 | 113th | 1 |
| H.R. 2055 | 112th | 1 |
| H.R. 1 | 112th | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.